The Association Between Knowledge About Gout Arthritis with NSAID and  Allopurinol Consumption in Rumah Susun Penjaringan

Brigita Naomi Santoso; Erfen Gustiawan Suwangto; Maria Riastuti Iryaningrum

doi:10.22146/rpcpe.58359

The Association Between Knowledge About Gout Arthritis with NSAID and Allopurinol Consumption in Rumah Susun Penjaringan

https://doi.org/10.22146/rpcpe.58359

Brigita Naomi Santoso⁽¹⁾, Erfen Gustiawan Suwangto^(2*), Maria Riastuti Iryaningrum⁽³⁾

(1) School of Medicine and Health Sciences; Atma Jaya Catholic University of Indonesia
(2) Department of Ethics and Law; School of Medicine and Health Sciences; Atma Jaya Catholic University of Indonesia
(3) Department of Internal Medicine; School of Medicine and Health Sciences; Atma Jaya Catholic University of Indonesia
(*) Corresponding Author

Abstract

Background: Health ministry is one of ministries in Indonesia who needs high fund every year. It is used for national health, starting from the availability of health infrastructure to the availability of medicine in health primary care and hospital. In Indonesia, there is a myth that joint pain is gout arthritis. In Indonesia, 71% people who have joint pain buy pain killer without going to get an examination by doctor first. Therefore, a research about the relationship between knowledge about gout arthritis and NSAID and Allopurinol consumption in Rumah Susun Penjaringan. Objective : Knowing if there is association between knowledge about gout arthritis and NSAID and Allopurinol consumption. Methods : This research used cross sectional study and involved 68 people in Rumah Susun Penjaringan. Result : There is no significant relationship between knowledge about gour arthritis with NSAID (p = 0.234) and Allopurinol (0.666) consumption in Rumah Susun Penjaringan. Conclusion : There is no relationship between knowledge about gout arthritis with NSAID and Allopurinol consumption in Rumah Susun Penjaringan.

Keywords

Allopurinol; consumption; gout arthritis; knowledge; NSAID

Full Text:

PDF

References

1. Ministry of Health, Republic of Indonesia. Health Field Study Seminar. Jakarta: Ministry of
Health, Republic of Indonesia; 2017.

2. Ministry of Health, Republic of Indonesia. Decree of the Minister of Health, Indonesia
number HK.01.07/Menkes/395/2017 Concerning the List of National Essential Medicines.
Jakarta: Ministry of Health, Republic of Indonesia; 2017.

3. Ministry of Finance, Republic of Indonesia. Indonesian Economy and 2017 State Budget
[Internet]. Jakarta: Ministry of Finance, Republic of Indonesia; 2017 [cited 2018 April 2].
Available from: https://www.kemenkeu.go.id/apbn2017.

4. Ministry of National Development Planning/Bappenas. Health Development Challenges in
Indonesia. Jakarta: Ministry of National Development Planning/Bappenas; 2017.

5. Farmalkes Ministry of Health, Republic of Indonesia. Use of generic drugs in Indonesia
reaches 70%. Jakarta: Directorate General of Pharmaceutical and Medical Devices,
Ministryof Health, Republic of Indonesia; 2014. Available from:
http://farmalkes.kemkes.go.id/2014/05/penggunaan-obat-generik-di-indonesia- capai-
70/#.WuWreMaB3R0.

6. Singh JA. Patient perspectives in gout: a review. Current Opinion in Rheumatology. 2019
Mar 1;31(2):159-66.

7. Zhang P, Mou Y, Gu J. Questionnaire survey evaluating hyperuricemia-related control
knowledge on 280 patients with gout [abstract]. In: Scientific Abstracts. United Kingdom:
Annals of the Rheumatic Diseases. 74 (Suppl2); 2015. 2015. 1290-91. AB1160.

8. Rolston CJ, Conner TS, Stamp LK, Neha T, Pitama S, Fanning N, et al. Improving gout
education from patients’ perspectives: a focus group study of Māori and Pākehā people with
gout. Journal of Primary Health Care. 2018 Oct 1;10(3):194-200.

9. Utomo WS, Supratman SK, Kep M, Yulian V. The effect of providing gout health education
on the knowledge and attitudes of gout sufferers in the Gatak Suharjo Community Health
Center [skripsi]. Surakarta: Faculty of Medicine, Universitas Muhammadiyah Surakarta;
2016.

10. Runtuwene Y, Purba RB, Kereh PS. Purine intake and knowledge level with uric acid levels
at the Rurukan Community Health Center, Tomohon City. Jurnal GIZIDO. 2016 Nov
1;8(2):1-10.

11. Foster JM, Faint N, Staton J, Stick S, Schultz A. The relationship between disease
knowledge, self-efficacy and adherence to treatment in adolescents with cystic fibrosis
[abstract]. In: Poster Discussion Session; San Francisco, 15 Mei 2016. New York: Am J
Respir Crit Care Med. 193; 2016: A2682.

12. Yeh JZ, Wei CJ, Weng SF, Tsai CY, Shih JH, Shih CL, et al. Disease-specific health literacy,
disease knowledge, and adherence behavior among patients with type 2 diabetes in Taiwan.
BMC Public Health. 2018 Dec;18(1):1-5.

13. Abbas A, Kachela B, Arif JM, Tahir KB, Shoukat N, Ali NB. Assessment of medication
adherence and knowledge regarding the disease among ambulatory patients with diabetes
mellitus DM in Karachi, Pakistan. Journal of Young Pharmacist. 2015;7(4):328-40.

14. Brown MT, Bussell J, Dutta S, Davis K, Strong S, Mathew S. Medication adherence: truth
and consequences. The American Journal of the Medical Sciences. 2016 Apr 1;351(4):387-
99.

15. Dunbar-Jacob J, Rohay JM. Predictors of medication adherence: fact or artifact. J Behav
Med. 2016 Dec;39(6):957-68.

16. Bilger M, Wong TT, Lee JY, Howard KL, Bundoc FG, Lamoureux EL, et al. Using
adherence-contingent rebates on chronic disease treatment costs to promote medication
adherence: results from a randomized controlled trial. Applied Health Economics and Health
Policy. 2019 Dec;17(6):841-55.

DOI: https://doi.org/10.22146/rpcpe.58359